Wissenschaftliche Arbeiten

Prof. Dr. Tayfur Toptaş

163 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Relaps/Refrakter Hodgkin Lenfomada Nivolumab: Çok Merkezli Türkiye Deneyimi Uzun Dönem Sonuçları

    AYBU AVESIS, 2019

    Quelle: OpenAlex

  2. A multi-centric study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia

    Turkish Journal of Hematology, 2019

    DOI 10.4274/tjh.galenos.2019.2018.0307 PMID 31327186 15 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  3. Clinical Features and Treatment Outcomes of Warm Autoimmune Hemolytic Anemia: A Retrospective Analysis of 60 Turkish Patients

    Indian Journal of Hematology and Blood Transfusion, 2019

    DOI 10.1007/s12288-019-01103-y PMID 31388268 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  4. The Effect of PET/CT Deauville Criteria on Progression Free Survival and Overall Survival in Multiple Myeloma Patients Following Autologous Stem Cell Transplantation

    Clinical Lymphoma Myeloma & Leukemia, 2019

    DOI 10.1016/j.clml.2019.09.496 1 Zitation (OpenAlex) Quelle: OpenAlex

  5. PB1955 REAL LIFE DATA OF NILOTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA RESISTANT OR INTOLERANT TO IMATINIB

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000566316.98256.dc 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  6. PB1953 QUALITY OF LIFE AND SYMPTOM BURDEN WITH FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000566308.21128.18 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  7. PB2235 SYMPTOM BURDEN AND SPLEEN SIZE RESPONSE WITH RUXOLUTINIB IN A REAL‐LIFE TURKISH COHORT

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000567416.09909.d5 Frei zugänglicher VolltextQuelle: OpenAlex

  8. PS1433 RESULTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS WITH RENAL FAILURE

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000564008.97747.a5 Frei zugänglicher VolltextQuelle: OpenAlex

  9. PB1947 COMPARISON OF EFFICACY AND SIDE EFFECTS OF SECONDLINE DASATINIB AND NILOTINIB THERAPIES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE RESISTANT OR INTOLERANT TO IMATINIB

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000566284.90632.fa Frei zugänglicher VolltextQuelle: OpenAlex

  10. Nörolojik Anlamlı Monoklonal Gammopati

    Turkiye Klinikleri Hematology - Special Topics, 2018

    Quelle: OpenAlex

  11. Düşük Riskli Miyelodisplastik Sendromda Tedavi

    Turkiye Klinikleri Hematology - Special Topics, 2018

    Quelle: OpenAlex

  12. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience

    Annals of Oncology, 2017

    DOI 10.1093/annonc/mdx341 PMID 28961828 45 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  13. Nivolumab for relapsed or refractory H odgkin lymphoma: Experience in T urkey

    Hematological Oncology, 2017

    DOI 10.1002/hon.2439_63 Frei zugänglicher VolltextQuelle: OpenAlex

  14. Efficacy of 18F-2-fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computerized Tomography for Bone Marrow Infiltration Assessment in the Initial Staging of Lymphoma

    Molecular Imaging and Radionuclide Therapy, 2017

    DOI 10.4274/mirt.54376 PMID 28613199 9 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  15. Molecular screening and the clinical impacts of BCR‑ABL KD mutations in patients with imatinib‑resistant chronic myeloid leukemia

    Oncology Letters, 2017

    DOI 10.3892/ol.2017.7606 PMID 29434953 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  16. 18F-FDG PET/CT Findings and Baseline Clinical Parameters in Multiple Myeloma

    Clinical Lymphoma Myeloma & Leukemia, 2017

    DOI 10.1016/j.clml.2017.03.267 Quelle: OpenAlex

  17. Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study

    Leukemia Research, 2016

    DOI 10.1016/j.leukres.2016.04.003 PMID 27107658 12 Zitationen (Europe PMC) Quelle: ORCID

  18. Hemoglobin H Disease in Turkey: Experience from Eight Centers

    Turkish Journal of Hematology, 2016

    DOI 10.4274/tjh.2014.0461 PMID 26376738 6 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  19. Efficacy of N-acetylcysteine in preventing amphotericin B induced acute kidney injury

    Marmara Medical Journal, 2016

    DOI 10.5472/mmjoa.2902.02 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  20. Post-thrombotic syndrome and venous disease-specific quality of life in patients with vascular Behçet's disease

    Journal of Vascular Surgery Venous and Lymphatic Disorders, 2016

    DOI 10.1016/j.jvsv.2016.01.003 PMID 27318049 33 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  21. Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate

    Clinical Lymphoma Myeloma & Leukemia, 2016

    DOI 10.1016/j.clml.2016.09.006 PMID 28082113 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  22. AB0540 Post-Thrombotic Syndrome and Venous Disease Spesific Quality of Life in Patients with Vascular Behçet's Disease

    Annals of the Rheumatic Diseases, 2016

    DOI 10.1136/annrheumdis-2016-eular.1238 1 Zitation (OpenAlex) Quelle: OpenAlex

  23. SUCCESSFUL TREATMENT OF SEVERE APLASTIC ANEMIA WITH ELTROMBOPAG: A CASE REPORT

    Medical Science and Discovery, 2016

    DOI 10.17546/msd.74493 Frei zugänglicher VolltextQuelle: OpenAlex

  24. Acute promyelocytic leukemia evolving from paroxysmal nocturnal hemoglobinuria: A rare occurrence

    Marmara medical journal, 2016

    DOI 10.5472/mmjcr.2902.02 Frei zugänglicher VolltextQuelle: OpenAlex

  25. Giant Intracranial Solitary Plasmacytoma

    Turkish Journal of Hematology, 2016

    DOI 10.4274/tjh.2016.0199 PMID 27531229 Frei zugänglicher VolltextQuelle: OpenAlex

  26. Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature

    International Journal of Hematology, 2015

    DOI 10.1007/s12185-015-1792-2 PMID 25833723 11 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  27. Documentation of renal glomerular and tubular impairment and glomerular hyperfiltration in multitransfused patients with beta thalassemia

    Annals of Hematology, 2015

    DOI 10.1007/s00277-015-2561-2 PMID 26596972 28 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  28. Efficacy and safety of eltrombopag in treatment-refractory primary immune thrombocytopenia

    Blood Coagulation & Fibrinolysis, 2015

    DOI 10.1097/mbc.0000000000000380 PMID 26258668 15 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  29. Miliary Tuberculosis Induced Acute Liver Failure

    Case Reports in Infectious Diseases, 2015

    DOI 10.1155/2015/759341 PMID 26435862 10 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  30. Quality of Life in Low-Risk Myelodysplastic Syndrome: A Cross-Sectional Study

    Blood, 2015

    DOI 10.1182/blood.v126.23.5256.5256 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  31. 250 DNA METHYLTRANSFERASE INHIBITORS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

    Leukemia Research, 2015

    DOI 10.1016/s0145-2126(15)30251-4 Quelle: OpenAlex

  32. 215 AZACYTIDINE IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

    Leukemia Research, 2015

    DOI 10.1016/s0145-2126(15)30216-2 Quelle: OpenAlex

  33. The impact of pre-transplant remission status on post-transplant disease outcomes in patients with multiple myeloma

    Dspace Repository (Marmara Üniversitesi), 2015

    Frei zugänglicher VolltextQuelle: OpenAlex

  34. Levofloxacin for the treatment of severe refractory BK virus-associated hemorrhagic cystitis in hematopoietic stem cell transplantation recipients: A report of three cases

    Oncology Letters, 2014

    DOI 10.3892/ol.2014.2381 PMID 25202408 13 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  35. Postpartum Ovarian Vein and Inferior Vena Cava Thrombosis

    Case Reports in Medicine, 2014

    DOI 10.1155/2014/609187 PMID 25114685 12 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  36. The efficiency of granulocyte colony-stimulating factor in hemorrhagic mucositis and febrile neutropenia resulted from methotrexate toxicity

    Cutaneous and Ocular Toxicology, 2014

    DOI 10.3109/15569527.2014.918139 PMID 24964172 9 Zitationen (OpenAlex) Quelle: OpenAlex

  37. Newly diagnosed breast cancer in a patient receiving imatinib mesylate

    Journal of Cancer Research and Therapeutics, 2014

    DOI 10.4103/0973-1482.146095 PMID 25579564 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  38. Quality-of-Life in Turkish Cancer Patients: The Impact of Sociodemographic Characteristics, Medical History, and Management.

    International Journal of Hematology and Oncology, 2014

    DOI 10.4999/uhod.13061 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  39. Author's reply: Predictors of aspirin resistance

    Upsala Journal of Medical Sciences, 2014

    DOI 10.3109/03009734.2014.918680 PMID 24835797 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  40. Comparison of DNA Methyltransferase Inhibitors in Patients with Myelodysplastic Syndrome

    Blood, 2014

    DOI 10.1182/blood.v124.21.5617.5617 Frei zugänglicher VolltextQuelle: OpenAlex

  41. Patterns of Complementary and Alternative Medicine Use among Turkish Cancer Patients

    Journal of Palliative Medicine, 2013

    DOI 10.1089/jpm.2012.0226 PMID 23305189 21 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  42. Ülkemizde İmmün Trombositopenide Eltrombopag Kullanımı On Bir Merkezin Deneyimi

    Kocaeli Üniversitesi - AVESİS, 2013

    Quelle: OpenAlex

  43. Aspirin resistance in patients with type II diabetes mellitus

    Upsala Journal of Medical Sciences, 2013

    DOI 10.3109/03009734.2013.861549 PMID 24236750 23 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  44. Prognostic impact of LIM domain only 2 ( LMO 2) in chronic myelogenous leukaemia

    Histopathology, 2013

    DOI 10.1111/his.12125 PMID 23879574 Quelle: OpenAlex

  45. Severe mucositis and febril neutropenia due to high dose methotrexate therapy

    Van Yüzüncü Yıl University Academic Data Management System, 2013

    Quelle: OpenAlex

  46. The Prognostic Value of CD49d Expression in Turkish Patients with Chronic Lymphocytic Leukemia

    Turkish Journal of Hematology, 2012

    DOI 10.5152/tjh.2012.03 8 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  47. Bortezomib in patients with renal impairment

    Hematology, 2011

    DOI 10.1179/102453311x13025568941880 PMID 21756535 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  48. Multiple organ failure caused by near-usual doses of colchicine

    Irish Journal of Medical Science (1971 -), 2011

    DOI 10.1007/s11845-011-0771-8 PMID 22012550 4 Zitationen (OpenAlex) Quelle: OpenAlex

  49. Additive effect of folic acid deficiency on pegylated interferonʼs bone marrow toxicity

    European Journal of Gastroenterology & Hepatology, 2011

    DOI 10.1097/meg.0b013e32834be999 PMID 21971342 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  50. Reliability of Caspase Activity as a Biomarker of Hepatic Apoptosis in Nonalcoholic Fatty Liver Disease

    Biomarkers in Medicine, 2011

    DOI 10.2217/bmm.11.70 PMID 22103615 6 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex